Celltrion | 068270 - 销售和管理费用

金融业

KRW

KRW 768.81B

现金及等价物

KRW 56.79B

KRW 92.83B

KRW 481.57B

KRW 292.71B

KRW 160.58B

股息收益率

0.38

KRW 13.41B

KRW 19.64B

1.07K

EPS每股收益

KRW 1.35K

股本和储备

KRW 434.82B

KRW 39.29B

债务利息支出

KRW 19B

KRW 779.01M

KRW 411.27B

KRW 37200.8B

KRW 8.82B

KRW 119.22B

KRW 12.9B

普通股股本

KRW 229.65M

58.97

KRW 11.84B

KRW 1240B

销售和管理费用

KRW 9.32B

KRW 126B

贸易债权人

KRW 88.58B

应收帐款人

KRW 2009.82B

	销售和管理费用	更改		日
Akebia Therapeutics	USD 23.53M		3.19M	2025-12
Alaunos Therapeutics	USD 447K		138K	2026-03
Avita Medical	AUD 19.03M		1.95M	2025-12
Celltrion	KRW 9.32B		3.39B	2026-03
Dianthus Therapeutics	USD 12.47M		5.89M	2026-03
Ionis Pharmaceuticals	USD 151M		21M	2026-03
IQVIA Holdings	USD 502M		34M	2026-03
Moderna	USD 173M		135M	2026-03
Organon & Co	USD 424M		9M	2026-03
Revvity	USD 253.88M		2.15M	2026-03
Tectonic Therapeutic	USD 6.43M		2.99M	2026-03
Viatris	USD 928.8M		101.9M	2026-03
Xeris Pharmaceuticals	USD 53.14M		10.51M	2026-03